Because of the autocrine stimulation of CCK2R by PDAC-secreted gastrin [17], competition between tumor gastrin and the reversible antagonist proglumide also may explain the greater fibrotic inhibition achieved by receptor downregulation. The gene discussed is CCKBR; the disease is neoplasm.